Total awarded
€221,000
Award notices won
5
Lots won
5
Last award
Jun 21, 2024
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0001 / Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) | Pharmaceutical products | supplies | €221,000 | - | DEU / Stuttgart | price |
LOT-0002 / Vertragsabschluss zum Arzneimittelwirkstoff Secukinumab, Verkaufsname: Cosentyx, Unternehmen: Novartis Pharma GmbH | Pharmaceutical products | supplies | - | - | DEU / Düsseldorf | - |
LOT-0002 / Vertragsabschluss zum Arzneimittelwirkstoff Omalizumab, Verkaufsname Xolair | Pharmaceutical products | supplies | - | - | DEU / Düsseldorf | - |
LOT-0002 / Vertragsabschluss zum Arzneimittelwirkstoff Sacubitril/Valsartan, Verkaufsname Entresto | Pharmaceutical products | supplies | - | - | DEU / Düsseldorf | quality |
LOT-0002 / Arzneimittelwirkstoff Canakinumab; Verkaufsname Ilaris | Pharmaceutical products | supplies | - | - | DEU / Düsseldorf | quality |
Award tenders
| Tender | Buyer | Publication date | Procedure | Award date | Awarded to contractor | Lots won |
|---|---|---|---|---|---|---|
| Abschluss von nicht exklusiven Rabattverträgen gemäß § 130a Abs. 8 SGB V zu Arzneimitteln (Open-House-Verfahren) 368592-2024 | AOK Baden-Württemberg | Jun 21, 2024 | open | Jun 03, 2024 | €221,000 | 1 |
| Vertragsabschluss zum Arzneimittelwirkstoff Secukinumab, Verkaufsname: Cosentyx, Unternehmen: Novartis Pharma GmbH 281032-2024 | AOK Rheinland/Hamburg | May 13, 2024 | neg-wo-call | Apr 28, 2024 | - | 1 |
| Vertragsabschluss zum Arzneimittelwirkstoff Omalizumab, Verkaufsname: Xolair, Unternehmen: Novartis Pharma GmbH 235966-2024 | AOK Rheinland/Hamburg | Apr 22, 2024 | neg-wo-call | Apr 07, 2024 | - | 1 |
| Vertragsabschluss zum Arzneimittelwirkstoff Sacubitril/Valsartan, Verkaufsname Entresto 65898-2024 | AOK Rheinland/Hamburg | Feb 01, 2024 | neg-wo-call | Jan 22, 2024 | - | 1 |
| Vertragsabschluss zum Arzneimittelwirkstoff Canakinumab, Verkaufsname Ilaris 47701-2024 | AOK Rheinland/Hamburg | Jan 24, 2024 | neg-wo-call | Jan 15, 2024 | - | 1 |
Company details
Identifiers
DE226556990
Countries
DEU
Cities
Nürnberg
Post codes
90429
Emails
CPV codes
Listed
true
About this contractor
Novartis Pharma GmbH is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.